China-based New Horizon Health, which produces home cancer test kits, has raised $66 million in a Series C round of funding led by VMS Group, a Hong Kong-based investment firm.
The company’s existing investors Legend Capital and Softbank China also re-upped. New Horizon raised its angel round of RMB5 million ($725,400) from Linhui Fund and Haibang Capital in 2013, while three...
US-based Liberty City Ventures has led a USD 359m round for Hong Kong blockchain media company Animoca Brands at a pre-money valuation of USD 5bn, more than double its valuation in October.
Harmay, a China-based omnichannel beauty products retailer, has raised USD 200m across Series C and D rounds.
Novotech, an Asia-based clinical trials specialist controlled by TPG Capital, has secured USD 760m in new equity and debt financing at a post-deal valuation of approximately USD 3bn.
Quadrant Private Equity has sold Journey Beyond, an Australia-based experiential tourism business, to US-based Hornblower Group, which is best known for offering cruise and sightseeing packages.